MIDATECH PHARMA PLC-ADR (MTP) Stock Price, Quote, News and Overview
NASDAQ:MTP - Nasdaq - US59564R5000 - ADR - Currency: USD
MTP Quote, Performance and Key Statistics
0.2851
-0.06 (-18.52%)
The current stock price of MTP is 0.2851 USD. In the past month the price decreased by -47.19%. In the past year, price decreased by -93.38%.
MTP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.17 | 360.64B | ||
| AMGN | AMGEN INC | 15.63 | 166.32B | ||
| GILD | GILEAD SCIENCES INC | 24.08 | 138.34B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1660.86 | 123.74B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.63 | 77.97B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.04B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.11B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.04B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.58B | ||
| NTRA | NATERA INC | N/A | 20.91B | ||
| BIIB | BIOGEN INC | 8.58 | 20.59B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.73 | 15.99B |
Related stock screener links
About MTP
Company Profile
Midatech Pharma Plc is a drug delivery technology company. The company is headquartered in Abingdon, Oxfordshire and currently employs 20 full-time employees. The company went IPO on 2014-12-08. The firm is focused on improving the bio-delivery and biodistribution of medicines. The firm's technologies include Q-Sphera, MidaSolve and MidaCore. Q-Sphera technology focusses on long acting injectables using three-dimensional (3D) printing technology. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. The company has a pipeline of approximately 10 earlier stage programmes, which includes MTD211 (Schizophrenia, MDD), MTD219 (Prophylaxis, transplant rejection), MTX223, MTX213, MTX214, MTX110 (Glioblastoma), MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma) and MTX114 (Psoriasis).
Company Info
MIDATECH PHARMA PLC-ADR
Oddfellows Hse, 19 Newport Road
Abingdon OXFORDSHIRE CF24 0AA GB
CEO: Stephen Stamp
Employees: 20
Company Website: http://www.midatechpharma.com/
Phone: 4401235888300.0
MIDATECH PHARMA PLC-ADR / MTP FAQ
What is the stock price of MIDATECH PHARMA PLC-ADR today?
The current stock price of MTP is 0.2851 USD. The price decreased by -18.52% in the last trading session.
What is the ticker symbol for MIDATECH PHARMA PLC-ADR stock?
The exchange symbol of MIDATECH PHARMA PLC-ADR is MTP and it is listed on the Nasdaq exchange.
On which exchange is MTP stock listed?
MTP stock is listed on the Nasdaq exchange.
What is MIDATECH PHARMA PLC-ADR worth?
MIDATECH PHARMA PLC-ADR (MTP) has a market capitalization of 1.98M USD. This makes MTP a Nano Cap stock.
How many employees does MIDATECH PHARMA PLC-ADR have?
MIDATECH PHARMA PLC-ADR (MTP) currently has 20 employees.
What are the support and resistance levels for MIDATECH PHARMA PLC-ADR (MTP) stock?
MIDATECH PHARMA PLC-ADR (MTP) has a resistance level at 0.56. Check the full technical report for a detailed analysis of MTP support and resistance levels.
Should I buy MIDATECH PHARMA PLC-ADR (MTP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MTP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MTP, evaluating the profitability, health, valuation and growth aspects
- MIDATECH PHARMA PLC-ADR (MTP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MIDATECH PHARMA PLC-ADR (MTP) Sales and EPS estimates to see what analysts future expectations are.
- MIDATECH PHARMA PLC-ADR (MTP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MIDATECH PHARMA PLC-ADR (MTP) Insider and Institutional Ownership to learn about the owners and their transactions.
- MIDATECH PHARMA PLC-ADR (MTP) Stock Chart to make your own analysis
- MIDATECH PHARMA PLC-ADR (MTP) Latest news and press-releases to stay up to date.
Does MIDATECH PHARMA PLC-ADR (MTP) stock pay dividends?
MTP does not pay a dividend.
When does MIDATECH PHARMA PLC-ADR (MTP) report earnings?
MIDATECH PHARMA PLC-ADR (MTP) will report earnings on 2023-04-24.
What is the Price/Earnings (PE) ratio of MIDATECH PHARMA PLC-ADR (MTP)?
MIDATECH PHARMA PLC-ADR (MTP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.96).
MTP Technical Analysis
MTP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MTP. MTP may be in some trouble as it scores bad on both profitability and health.
MTP Financial Highlights
Over the last trailing twelve months MTP reported a non-GAAP Earnings per Share(EPS) of -0.96. The EPS increased by 58.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.07 |
MTP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to MTP. The Buy consensus is the average rating of analysts ratings from 7 analysts.